Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pandoraon Dec 15, 2021 2:24pm
117 Views
Post# 34233888

RE:RE:RE:RE:RE:RE:RE:News….that sux

RE:RE:RE:RE:RE:RE:RE:News….that sux
biorun wrote:

Every time the obvious is starring people in the face and I share my views, lots of horse power to discredit here. Use it people to buy at cheap prices if that works for everyone. 

Bottom line, take the emotional aspects and your howie this howie that out of the equation and just look at this for what it is:

1) the company remains on track to the very best of everyone's knowledge to sign a contract with a top 10 pharma. There has been ZERO tangible evidence to discredit this plan from any credible source - industry or otherwise.

2) the world is blowing up again with Omicron and even pfizer's pill is not totally cutting the mustard. Sirona has an anti-viral that very much looks to be able to compete here, based upon a different attack mechanism. Yes it will take time, but with a partner this could change quickly.

3) the anti-aging is advancing rapidly through preparation and much more to look forward to. 
 

have fun everyone, and wish everyone a good Christmas!



From a time line point of view, in looking at SBM's past history, by the time they get an antiviral to the market stage no one will likely remember covid or delta or omicron and many of us will likely not be on this side of the grass. Not sure it is a factor to decide your investment on.
<< Previous
Bullboard Posts
Next >>